Influence of smoking on the efficacy of antimalarials in cutaneous lupus: A meta-analysis of the literature

Journal of the American Academy of Dermatology

Volumn 72, Issue 4, 2015, Pages 634-639

  Chasset, François ^a,b   Francès, Camille ^b,c   Barete, Stéphane ^b,c   Amoura, Zahir ^a,c   Arnaud, Laurent ^a,c,d  

^a French National Reference Center for Systemic Lupus Erythematosus   (France)

^b HÔPITAL TENON   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d INSTITUT PIERRE LOUIS D EPIDÉMIOLOGIE ET DE SANTÉ PUBLIQUE   (France)

Author keywords

cutaneous; hydroxychloroquine; Key words antimalarials; lupus erythematosus; smoking; tobacco

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; HYDROXYCHLOROQUINE;

ADULT; ARTICLE; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HUMAN; MALE; META ANALYSIS; PRIORITY JOURNAL; SKIN LUPUS ERYTHEMATOSUS; SMOKING; SMOKING CESSATION; SYSTEMATIC REVIEW; TREATMENT OUTCOME; BLOOD; CICATRIX; COMORBIDITY; DRUG RESISTANCE; EPIDEMIOLOGY; LUPUS ERYTHEMATOSUS, CUTANEOUS; OBSERVATIONAL STUDY; PATHOLOGY; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; RISK; SEVERITY OF ILLNESS INDEX;

ANTIMALARIALS; CAUSALITY; CHLOROQUINE; CICATRIX; COMORBIDITY; DRUG RESISTANCE; HUMANS; HYDROXYCHLOROQUINE; LUPUS ERYTHEMATOSUS, CUTANEOUS; OBSERVATIONAL STUDY AS TOPIC; ODDS RATIO; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SMOKING; SMOKING CESSATION;

EID: 84929511411     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2014.12.025     Document Type: Article

References (25)

1. N. Ezra, and J. Jorizzo Hydroxychloroquine and smoking in patients with cutaneous lupus erythematosus Clin Exp Dermatol 37 2012 327 334
2. C. Francès, A. Cosnes, and P. Duhaut Low blood concentration of hydroxychloroquine in patients with refractory cutaneous lupus erythematosus: a French multicenter prospective study Arch Dermatol 148 2012 479 484
3. S. Wahie, A.K. Daly, and H.J. Cordell Clinical and pharmacogenetic influences on response to hydroxychloroquine in discoid lupus erythematosus: a retrospective cohort study J Invest Dermatol 131 2011 1981 1986
4. R.D. Sontheimer Clinical manifestations of cutaneous lupus erythematosus D.J. Wallace, B.H. Hahn, Dubois' lupus erythematosus 1993 Lea and Febiger Philadelphia (PA) 285 301
5. D.F. Stroup, J.A. Berlin, and S.C. Morton Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group JAMA 283 2000 2008 2012
6. A. Stang Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses Eur J Epidemiol 25 2010 603 605
7. A. Kuhn, J. Sigges, and C. Biazar Influence of smoking on disease severity and antimalarial therapy in cutaneous lupus erythematosus: analysis of 1002 patients from the EUSCLE database Br J Dermatol 171 2014 571 579
8. E.W. Piette, K.P. Foering, and A.Y. Chang Impact of smoking in cutaneous lupus erythematosus Arch Dermatol 148 2012 317 322
9. R. Klein, S. Moghadam-Kia, and J. LoMonico Development of the CLASI as a tool to measure disease severity and responsiveness to therapy in cutaneous lupus erythematosus Arch Dermatol 147 2011 203 208
10. N. Yokogawa, A. Tanikawa, and M. Amagai Response to hydroxychloroquine in Japanese patients with lupus-related skin disease using the cutaneous lupus erythematosus disease area and severity index (CLASI) Mod Rheumatol 23 2013 318 322
11. D. Lardet, S. Martin, F. Truchetet, J.F. Cuny, J.M. Virion, and J.L. Schmutz Effect of smoking on the effectiveness of antimalarial drugs for cutaneous lesions of patients with lupus: assessment in a prospective study [in French] Rev Med Interne 25 2004 786 791
12. A. Kreuter, N. Scola, C. Tigges, P. Altmeyer, and T. Gambichler Clinical features and efficacy of antimalarial treatment for reticular erythematous mucinosis: a case series of 11 patients Arch Dermatol 147 2011 710 715
13. A. Kreuter, R. Gaifullina, C. Tigges, J. Kirschke, P. Altmeyer, and T. Gambichler Lupus erythematosus tumidus: response to antimalarial treatment in 36 patients with emphasis on smoking Arch Dermatol 145 2009 244 248
14. M.L. Jewell, and D.P. McCauliffe Patients with cutaneous lupus erythematosus who smoke are less responsive to antimalarial treatment J Am Acad Dermatol 42 2000 983 987
15. P. Rahman, D.D. Gladman, and M.B. Urowitz Smoking interferes with efficacy of antimalarial therapy in cutaneous lupus J Rheumatol 25 1998 1716 1719
16. J. Bourré-Tessier, C.A. Peschken, and S. Bernatsky Association of smoking with cutaneous manifestations in systemic lupus erythematosus Arthritis Care Res 65 2013 1275 1280
17. I. Turchin, S. Bernatsky, A.E. Clarke, Y. St-Pierre, and C.A. Pineau Cigarette smoking and cutaneous damage in systemic lupus erythematosus J Rheumatol 36 2009 2691 2693
18. S. Wanwimolruk, S.M. Wong, P.F. Coville, S. Viriyayudhakorn, and S. Thitiarchakul Cigarette smoking enhances the elimination of quinine Br J Clin Pharmacol 36 1993 610 614
19. J.R. Schein Cigarette smoking and clinically significant drug interactions Ann Pharmacother 29 1995 1139 1148
20. G. Leroux, N. Costedoat-Chalumeau, and J.S. Hulot Relationship between blood hydroxychloroquine and desethylchloroquine concentrations and cigarette smoking in treated patients with connective tissue diseases Ann Rheum Dis 66 2007 1547 1548
21. D. Bein, E. Kuehn, and A.M. Meuth Evaluation of disease activity and damage in different subtypes of cutaneous lupus erythematosus using the CLASI J Eur Acad Dermatol Venereol 25 2011 652 659
22. A. Kuhn, A.M. Meuth, and D. Bein Revised Cutaneous Lupus Erythematosus Disease Area and Severity Index (RCLASI): a modified outcome instrument for cutaneous lupus erythematosus Br J Dermatol 163 2010 83 92
23. C. Biazar, J. Sigges, and N. Patsinakidis Cutaneous lupus erythematosus: first multicenter database analysis of 1002 patients from the European Society of Cutaneous Lupus Erythematosus (EUSCLE) Autoimmun Rev 12 2013 444 454
24. N. Costedoat-Chalumeau, Z. Amoura, and J.S. Hulot Very low blood hydroxychloroquine concentration as an objective marker of poor adherence to treatment of systemic lupus erythematosus Ann Rheum Dis 66 2007 821 824
25. S. Degroote, D. Vogelaers, and P. Vermeir Determinants of adherence in a cohort of Belgian HIV patients: a pilot study Acta Clin Belg 69 2014 111 115